GINZA NOA CLINIC
Tokyo, Japan International Patient Support
Contact Us

How Long Should I Stay in Japan for Treatment?

For outpatient stem cell treatment in Japan, plan to stay from your first required in-person assessment through your final review and the treating doctor’s clearance for your journey home. A procedure date alone is not enough to book a return flight. If your plan involves cell collection followed by processing, you may need separate visits; ask whether you can leave Japan between them. Blood stem cell transplantation is a different, months-long commitment: NCI describes going home about 100 days after receiving donor cells if there are no problems [1].

What the Stay Estimates Mean

There is no single outpatient stay length that this article can substantiate for every diagnosis, cell product, and procedure. A clinic’s estimate should specify the first appointment, treatment date, observation period, final review, and conditions that could delay departure. This guide focuses on stem cell treatment planning, not every type of medical care in Japan.

How Long Should I Stay in Japan for Treatment?

For donor-cell transplantation, NCI’s roughly 100-day example starts when the donor cells are given, not when you arrive in Japan. Assessment and preparation may come earlier. NCI also describes hospital visits two or three times a week after discharge. Hospital admission, nearby accommodation when out of hospital, and later follow-up are different parts of that pathway; the figure is not a promise of a fixed discharge or flight date, nor a Japan-specific rule [1].

Why Your Treatment Plan Matters

An outpatient joint injection, an IV infusion, and a blood stem cell transplant do not share a recovery schedule. Your diagnosis, health history, collection method, product preparation, administration route, and response to the procedure all affect the appointments and observation you may need. An overnight stay or an extra trip does not establish that a treatment is effective.

The FDA warns about misleading claims and significant safety concerns involving unapproved regenerative medicine products. Its consumer guidance concerns US regulation, not permission to provide treatment in Japan [2]. In Japan, the framework governing provision of regenerative medicine is separate from the framework for commercial medical-product approval. A clinic’s provision-plan filing is not product marketing approval or proof of clinical benefit [3].

Ask which route applies to the exact product and indication: an approved use, an experimental intervention in a clinical trial, or a private clinic service. These labels do not supply a day count. Get the treatment-specific schedule and eligibility decision from the treating doctor; the site’s overview of treatment indications and contraindications can help you prepare questions, but cannot establish whether you personally qualify.

Where Your Days Go

Ask the clinic to map each relevant step to a date. Not every plan needs all the steps below, and several may happen on the same day.

StepWhat may affect the scheduleWhat to confirm
In-person assessment and consentAn examination, blood tests, or scan review may still be neededRequired tests, result turnaround, and what could rule out treatment
Cell collection, if requiredCollection may have its own preparation, recovery, and reviewCollection method, anesthesia if any, and aftercare appointments
Processing or product preparationSome plans have a gap before administrationThe expected gap, release requirements, and whether you may leave Japan
TreatmentAdministration and post-procedure observation both take timeObservation arrangements and discharge criteria
Early reviewWound checks, test results, or symptoms may require reassessmentReview dates and how close you need to remain to the clinic
Fitness-to-travel assessmentRecovery and the length and complexity of your journey matterWho will assess your proposed flight and whether airline documentation is needed
Records and follow-up handoverYour home doctor needs the information required for ongoing careDischarge summary, procedure and product details, medicines, and follow-up responsibilities

CDC guidance on medical tourism emphasizes planning for complications, obtaining records, and arranging follow-up [4]. Use the treatment process in Japan and the medical travel preparation guide to organize questions for your provider, rather than treating a general process description as your personal itinerary.

Three Ways to Plan the Trip

One Outpatient Trip

If all necessary care can fit within one trip, confirm whether assessment, treatment, and review fall on the same or separate days. Ask when test results will be available and whether any appointment depends on those results. Do not assume the day after treatment is automatically a safe departure date.

Separate Visits With a Gap

If your own cells must be collected and processed before administration, ask whether the plan actually requires two visits and how long the gap may be. Using your own cells does not, by itself, prove that you need two trips to Japan. If separate visits are required, obtain medical advice on whether you can go home between them and what would happen if processing or product release is delayed.

Compare accommodation during the gap with the cost and strain of another journey. Get storage fees, cancellation terms, repeat-assessment requirements, and responsibility for additional costs in writing. The overview of treatment costs in Japan can help you identify items to ask about in a patient-specific quote.

A Transplant Program

Blood stem cell transplantation for cancer and related conditions belongs to a specialist transplant pathway, not a short outpatient itinerary. Ask the transplant center about preparation, inpatient care, nearby housing after discharge, caregiver arrangements, and the criteria for returning home. NCI’s general timeline cannot replace the center’s plan [1]. When considering the choice of hospital, ask specifically whether it provides the proposed procedure and the required follow-up; a general stem cell service is not necessarily a transplant center.

Check Your Booking Against the Plan

Consider a planning scenario, not a patient case: you have a treatment appointment, but the clinic has not yet confirmed when the doctor will review your results. You cannot reliably set your return flight from that appointment alone. Ask for the result-review date, the earliest proposed travel date, and the conditions that could move either one.

A coordinator’s appointment confirmation is not the same as the treating doctor’s approval of your treatment or your flight home.

Before paying for non-refundable bookings, check that you have a named medical contact, a dated schedule, and a plan for after-hours problems. Keep the schedule with your travel documents. This scenario illustrates a planning check; it does not report clinical experience or predict how any patient’s treatment will go.

Allow for Delays and Entry Rules

Missing records, additional testing, a change in eligibility, or a delay in product preparation may shift the schedule. Ask which dates are provisional and who pays for extra accommodation or rebooking. Discuss a suitable buffer with the treating team instead of assuming that a fixed number of spare nights will cover every complication.

Check entry and visa requirements for your passport with Japan’s Ministry of Foreign Affairs or the relevant Japanese embassy or consulate before committing to travel. Do not assume your permitted stay will cover an extension of treatment [5]. Also confirm the clinic’s actual opening days: weekends and public holidays can interrupt appointments, testing, or paperwork.

Check whether your insurance covers planned treatment abroad and related complications, rather than ordinary holiday travel alone. Keep accessible copies of your records, medicine list, allergies, and emergency contacts. Arrange follow-up at home before departure, including who will review results and respond if problems arise [4].

When Not to Board Your Flight

Sudden breathing difficulty, chest or upper-back pain, or fainting requires emergency medical assessment, not just a message to the clinic or a later appointment. NHS guidance identifies these as possible signs of pulmonary embolism or another serious condition [6]. Seek emergency help locally and do not proceed with your flight while awaiting assessment.

For fever, worsening redness, pain or swelling at a collection or injection site, unusual bleeding, rash, or another symptom flagged in your discharge instructions, contact the treating team promptly for advice on assessment and travel. New calf pain or swelling also needs urgent medical advice, particularly with breathing symptoms [6]. Transplant recipients should follow their center’s specific emergency and follow-up instructions [1].

Questions to Settle Before Booking

  • What exact treatment, product, administration route, and indication are proposed, and what is the legal route in Japan?
  • Which appointments require my presence, and which dates remain provisional?
  • If collection and administration are separate, may I leave Japan between them?
  • What tests or product-release requirements could postpone treatment?
  • What observation and review are required before I can leave the clinic and travel home?
  • Who assesses my actual flight itinerary, and what happens if I am not ready to fly?
  • Who handles complications, extra costs, refunds, and follow-up after I leave?

The Bottom Line

For outpatient care, book around your complete patient-specific schedule and travel assessment, not just the procedure. A processing gap may mean a longer stay or separate trips. Donor-cell transplantation requires a specialist, months-long plan; the roughly 100-day NCI example is not a universal departure deadline [1].

If you already have scan files and a rough travel window, send your dates and questions in one message so the team can match them to a written plan.

Contact the Patient Support Team

References

  1. [1] National Cancer Institute, Stem Cell Transplant — accessed 2026-11-16.
  2. [2] US FDA, Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes — accessed 2026-11-16.
  3. [3] PMDA, Regenerative Medical Products — accessed 2026-11-16.
  4. [4] CDC Yellow Book, Medical Tourism — prior access recorded 2026-11-16.
  5. [5] Ministry of Foreign Affairs of Japan, Visa Information — prior access recorded 2026-11-16.
  6. [6] NHS, Pulmonary Embolism — accessed 2026-11-16.